🇺🇸 Triatec HCT 5 in United States

14 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Abdominal Pain Upper — 2 reports (14.29%)
  2. Diarrhoea — 2 reports (14.29%)
  3. Drug Interaction — 2 reports (14.29%)
  4. Vomiting — 2 reports (14.29%)
  5. Acute Kidney Injury — 1 report (7.14%)
  6. Agitation — 1 report (7.14%)
  7. Anaphylactoid Reaction — 1 report (7.14%)
  8. Angioedema — 1 report (7.14%)
  9. Asthenia — 1 report (7.14%)
  10. Atrial Fibrillation — 1 report (7.14%)

Source database →

Triatec HCT 5 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Triatec HCT 5 approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Triatec HCT 5 in United States?

Heart Care Foundation is the originator. The local marketing authorisation holder may differ — check the official source linked above.